Skip to main content
. 2021 Oct 7;8(5):503–510. doi: 10.1093/ehjcvp/pvab075

Table 3.

Safety events

Placebo (n = 55) Anakinra (n = 84) P-value
Serious infections (%) 7 (13) 11 (13) 1.0
Injection site reaction (%) 3 (5) 19 (23) 0.016
Injection site reaction leading to discontinuation (%) 1 (2) 6 (7) 0.160
Death (%) 2 (4) 0 (0) 0.155